EXCLUSIVE LICENSE AGREEMENT BETWEEN THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. AND TERAIMMUNE, INC.Exclusive License Agreement • August 16th, 2023 • Baudax Bio, Inc. • Services-misc health & allied services, nec • Maryland
THIS EXCLUSIVE LICENSE AGREEMENT is entered into as of the date of the last signature on the signature page of this document (the “Effective Date”), by and between The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a tax-exempt corporation organized under the laws of the State of Maryland and having its principal offices at 6720A Rockledge Drive, Suite 100, Bethesda, Maryland 20817 (“HJF”) and TeraImmune, Inc., a corporation organized under the laws of Delaware and having its principal offices 704 Quince Orchard Rd, Ste 160, Gaithersburg, MD 20878 (“TeraImmune” or “Licensee”). HJF and Licensee sometimes are referred to collectively herein as the “Parties” or individually as a “Party.”
ContractLicense Agreement • August 16th, 2023 • Baudax Bio, Inc. • Services-misc health & allied services, nec
[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and the registrant customarily and actually treats as private and confidential.
PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT – EXCLUSIVE This Agreement is based on the model Patent License Exclusive Agreement adopted by the U.S. Public Health Service (“PHS”) Technology Transfer Policy Board for use by components of the National...Patent License Agreement – Exclusive • August 16th, 2023 • Baudax Bio, Inc. • Services-misc health & allied services, nec
This Patent License Agreement, hereinafter referred to as the “Agreement”, consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Benchmarks and Performance), Appendix E (Commercial Development Plan), Appendix F (Example Royalty Report), and Appendix G (Royalty Payment Options).
